ImmuCell Co. (NASDAQ:ICCC – Get Free Report)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.13 and traded as high as $5.36. ImmuCell shares last traded at $5.02, with a volume of 11,233 shares traded.
ImmuCell Trading Down 6.9 %
The company has a 50 day moving average of $4.88 and a 200 day moving average of $4.13. The firm has a market cap of $44.73 million, a price-to-earnings ratio of -10.04 and a beta of 0.54. The company has a current ratio of 3.11, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36.
About ImmuCell
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.
Further Reading
- Five stocks we like better than ImmuCell
- Best Stocks Under $10.00
- How to Invest in Small Cap Stocks
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- These Are the Dividend Stocks Insiders Bought in January
- Want to Profit on the Downtrend? Downtrends, Explained.
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with MarketBeat.com's FREE daily email newsletter.
